Biotechnology News

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific billing code for Otulfi® (ustekinumab-aauz). Under the Healthcare Common Procedure Coding System (HCPCS), the Q-code Q9999 is for “Injection, for subcutaneous use or intravenous use, ustekinumab-aauz (Otulfi), biosimilar per 1.0 mg.” Otulfi (ustekinumab-aauz) is FDA-approved for subcutaneous and intr...

HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the appointment of Tatyana Kosheleva as Chief Financial Officer, effective April 28, 2025. Her appointment is part of a broader evolution of the company’s leadership team, reflecting NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth. Kosheleva brings more than 20 years of global financial leadership experience across...

LYON, France--(BUSINESS WIRE)--MaaT Pharma Presents Preclinical Data at AACR Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in Pharmaceutical Innovation The report provides insights into Boehringer Ingelheim's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehr...

LAS VEGAS--(BUSINESS WIRE)--ASEMBIA AXS25 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced today the availability of Patient Watchtower, the first and only care coordination platform for specialty and rare disease patients. SaaS-based Patient Watchtower seamlessly merges complex and fragmented patient data from various sources and creates immediate actionable insights. It uses artificial intelligence and machine learning (AIML) to ena...

LOS ANGELES--(BUSINESS WIRE)--A team led by Children's Hospital Los Angeles (CHLA) has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential “bridge” to heart transplant for critically ill babies. The groundbreaking preclinical research could lead to a lifesaving alternative for supporting critically ill babies waiting for a new heart—particularly those with single-ventricle heart disease, most of whom currently die while waiting...

SAN MATEO, Calif.--(BUSINESS WIRE)--EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader of c-Met, a potential first-in-class therapy for a range of cancers driven by mutated, amplified, or overexpressed c-Met signaling. The data, which were presented in a poster at the American Association for Cancer Research (AACR) Annual Meeting, show that c-Met degrading EpiTACs demonstrate strong...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a leading clinical-stage company developing anchored drug conjugates for the treatment of cancer, today presented preliminary data highlighting the safety and biologic activity of their lead asset, tolododekin alfa (ANK-101), an anchored interleukin-12 (IL-12) drug conjugate. The data was derived from Part 1 of the first-in-human (FIH) ANCHOR Phase 1 clinical trial. The study was designed to evaluate the safety and feasibility of tolododek...

ATLANTA--(BUSINESS WIRE)--Curant Health, a multifaceted Medication Care Management® organization dedicated to the care of complex patients nationwide, is proud to announce the launch of its PlanPlus™ business unit. PlanPlus™ is solely focused on improving the clinical health outcomes of Health Plan member populations via award-winning complex care patient services, and unmatched business intelligence capabilities. Curant Health is URAC, ACHC, NABP and HITRUST certified with 12 IRB clinical stud...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, in partnership with Spatomics, which specializes in developing spatial biology research tools, today presents a poster at AACR detailing a highly sensitive, multiplexed single-cell in situ analysis method that enables simultaneous detection of ten or more protein and glycan ta...